FinnCap reaffirmed their corporate rating on shares of Proteome Sciences plc (LON:PRM) in a research note issued to investors on Thursday morning.

Shares of Proteome Sciences plc (LON:PRM) opened at 10.375 on Thursday. Proteome Sciences plc has a 1-year low of GBX 10.25 and a 1-year high of GBX 23.94. The firm’s market cap is GBX 23.65 million. The stock has a 50 day moving average of GBX 14.60 and a 200 day moving average of GBX 16.60.

Proteome Sciences plc Company Profile

Proteome Sciences plc is a protein biomarker company. The Company’s principal activity includes biomarker research and development in applied proteomics and workflows using techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications.

Receive News & Ratings for Proteome Sciences plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences plc and related companies with Analyst Ratings Network's FREE daily email newsletter.